In this study, we evaluated the metabolic consequences of different TP53 mutations in three EAC cell models, OE33, OE19, and FLO1, which represent distinct stages of tumor differentiation and harbor missense or loss-of-function mutations in TP53. Here, TP53 is linked to neoplasm.